These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 17286158)

  • 1. Treatment of cutaneous T-cell lymphoma/mycosis fungoides.
    Parker SR; Bradley B
    Dermatol Nurs; 2006 Dec; 18(6):566-70, 573-5. PubMed ID: 17286158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions.
    Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
    J Am Acad Dermatol; 2014 Feb; 70(2):223.e1-17; quiz 240-2. PubMed ID: 24438970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous T cell lymphoma-mycosis fungoides and Sezary syndrome: an update.
    Parker SR; Bethaney JV
    G Ital Dermatol Venereol; 2009 Aug; 144(4):467-85. PubMed ID: 19755952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic monotherapy vs combination therapy for CTCL: rationale and future strategies.
    Duvic M
    Oncology (Williston Park); 2007 Feb; 21(2 Suppl 1):33-40. PubMed ID: 17474358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A brief primer on treatments of cutaneous T cell lymphoma, newly approved or late in development.
    Scheinfeld N
    J Drugs Dermatol; 2007 Jul; 6(7):757-60. PubMed ID: 17763605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Denileukin diftitox plus total skin electron beam radiation in patients with treatment-refractory cutaneous T-cell Lymphoma (mycosis fungoides): report of four cases.
    Buder K; Müller PA; Beckmann G; Ugurel S; Bröcker EB; Becker JC
    Acta Derm Venereol; 2014 Jan; 94(1):94-6. PubMed ID: 23756575
    [No Abstract]   [Full Text] [Related]  

  • 7. Mycosis fungoides.
    Pitman J; Muekusch G
    Dermatol Nurs; 2007 Aug; 19(4):377. PubMed ID: 17874608
    [No Abstract]   [Full Text] [Related]  

  • 8. Diagnosis and management of mycosis fungoides.
    Galper SL; Smith BD; Wilson LD
    Oncology (Williston Park); 2010 May; 24(6):491-501. PubMed ID: 20568590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor activity of DAB389IL-2 fusion toxin in mycosis fungoides.
    Saleh MN; LeMaistre CF; Kuzel TM; Foss F; Platanias LC; Schwartz G; Ratain M; Rook A; Freytes CO; Craig F; Reuben J; Sams MW; Nichols JC
    J Am Acad Dermatol; 1998 Jul; 39(1):63-73. PubMed ID: 9674399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rational therapy for cutaneous T-cell lymphomas in the 1990s. Fact or fancy?
    Bunn PA
    Arch Dermatol; 1995 May; 131(5):603-5. PubMed ID: 7537952
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of mycosis fungoides with denileukin diftitox and oral bexarotene.
    Talpur R; Duvic M
    Clin Lymphoma Myeloma; 2006 May; 6(6):488-92. PubMed ID: 16796781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The diagnosis, staging, and treatment options for mycosis fungoides.
    Keehn CA; Belongie IP; Shistik G; Fenske NA; Glass LF
    Cancer Control; 2007 Apr; 14(2):102-11. PubMed ID: 17387295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poikilodermatous mycosis fungoides.
    Farley-Loftus R; Mandal R; Latkowski JA
    Dermatol Online J; 2010 Nov; 16(11):8. PubMed ID: 21163159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mycosis fungoides].
    Richard-Lallemand MA; Carsuzaa F
    Ann Dermatol Venereol; 1997; 124(1):69-90. PubMed ID: 9686047
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of cutaneous T cell lymphoma: current status and future directions.
    Apisarnthanarax N; Talpur R; Duvic M
    Am J Clin Dermatol; 2002; 3(3):193-215. PubMed ID: 11978140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Denileukin diftitox therapy for patients with tumour-stage mycosis fungoides.
    Assaf C
    Dermatol Clin; 2008 Jan; 26 Suppl 1():21-2. PubMed ID: 18405182
    [No Abstract]   [Full Text] [Related]  

  • 17. Choosing a systemic treatment for advanced stage cutaneous T-cell lymphoma: mycosis fungoides and Sézary syndrome.
    Duvic M
    Hematology Am Soc Hematol Educ Program; 2015; 2015():529-44. PubMed ID: 26637769
    [No Abstract]   [Full Text] [Related]  

  • 18. Cytokines and other biologic agents as immunotherapeutics for cutaneous T-cell lymphoma.
    Rook AH; Junkins-Hopkins JM; McGinnis KS; Wysocka M; Richardson SK; Budgin JB; Everitts S; Vittorio CC
    Adv Dermatol; 2002; 18():29-43. PubMed ID: 12528401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Choices in the treatment of cutaneous T-cell lymphoma.
    Hymes KB
    Oncology (Williston Park); 2007 Feb; 21(2 Suppl 1):18-23. PubMed ID: 17474355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythema gyratum repens-like eruptions with large cell transformation in a patient with mycosis fungoides.
    Holcomb M; Duvic M; Cutlan J
    Int J Dermatol; 2012 Oct; 51(10):1231-3. PubMed ID: 21726213
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.